176 related articles for article (PubMed ID: 27997721)
21. Chlamydia trachomatis development requires both host glycolysis and oxidative phosphorylation but has only minor effects on these pathways.
N'Gadjaga MD; Perrinet S; Connor MG; Bertolin G; Millot GA; Subtil A
J Biol Chem; 2022 Sep; 298(9):102338. PubMed ID: 35931114
[TBL] [Abstract][Full Text] [Related]
22. Regulation of carbon metabolism in Chlamydia trachomatis.
Iliffe-Lee ER; McClarty G
Mol Microbiol; 2000 Oct; 38(1):20-30. PubMed ID: 11029687
[TBL] [Abstract][Full Text] [Related]
23. A novel co-infection model with Toxoplasma and Chlamydia trachomatis highlights the importance of host cell manipulation for nutrient scavenging.
Romano JD; de Beaumont C; Carrasco JA; Ehrenman K; Bavoil PM; Coppens I
Cell Microbiol; 2013 Apr; 15(4):619-46. PubMed ID: 23107293
[TBL] [Abstract][Full Text] [Related]
24. An NlpC/P60 protein catalyzes a key step in peptidoglycan recycling at the intersection of energy recovery, cell division and immune evasion in the intracellular pathogen Chlamydia trachomatis.
Reuter J; Otten C; Jacquier N; Lee J; Mengin-Lecreulx D; Löckener I; Kluj R; Mayer C; Corona F; Dannenberg J; Aeby S; Bühl H; Greub G; Vollmer W; Ouellette SP; Schneider T; Henrichfreise B
PLoS Pathog; 2023 Feb; 19(2):e1011047. PubMed ID: 36730465
[TBL] [Abstract][Full Text] [Related]
25. Effect of host fatty acid-binding protein and fatty acid uptake on growth of Chlamydia trachomatis L2.
Wang G; Burczynski F; Anderson J; Zhong G
Microbiology (Reading); 2007 Jun; 153(Pt 6):1935-1939. PubMed ID: 17526850
[TBL] [Abstract][Full Text] [Related]
26. In contrast to Chlamydia trachomatis, Waddlia chondrophila grows in human cells without inhibiting apoptosis, fragmenting the Golgi apparatus, or diverting post-Golgi sphingomyelin transport.
Dille S; Kleinschnitz EM; Kontchou CW; Nölke T; Häcker G
Infect Immun; 2015 Aug; 83(8):3268-80. PubMed ID: 26056386
[TBL] [Abstract][Full Text] [Related]
27. Activation of epidermal growth factor receptor is required for Chlamydia trachomatis development.
Patel AL; Chen X; Wood ST; Stuart ES; Arcaro KF; Molina DP; Petrovic S; Furdui CM; Tsang AW
BMC Microbiol; 2014 Dec; 14():277. PubMed ID: 25471819
[TBL] [Abstract][Full Text] [Related]
28. Chlamydia trachomatis Relies on Autonomous Phospholipid Synthesis for Membrane Biogenesis.
Yao J; Cherian PT; Frank MW; Rock CO
J Biol Chem; 2015 Jul; 290(31):18874-88. PubMed ID: 25995447
[TBL] [Abstract][Full Text] [Related]
29. Parallel labeling experiments with [1,2-(13)C]glucose and [U-(13)C]glutamine provide new insights into CHO cell metabolism.
Ahn WS; Antoniewicz MR
Metab Eng; 2013 Jan; 15():34-47. PubMed ID: 23111062
[TBL] [Abstract][Full Text] [Related]
30. Analysis of Melanoma Cell Glutamine Metabolism by Stable Isotope Tracing and Gas Chromatography-Mass Spectrometry.
Scott DA
Methods Mol Biol; 2021; 2265():91-110. PubMed ID: 33704708
[TBL] [Abstract][Full Text] [Related]
31. Pathogenic Chlamydia Lack a Classical Sacculus but Synthesize a Narrow, Mid-cell Peptidoglycan Ring, Regulated by MreB, for Cell Division.
Liechti G; Kuru E; Packiam M; Hsu YP; Tekkam S; Hall E; Rittichier JT; VanNieuwenhze M; Brun YV; Maurelli AT
PLoS Pathog; 2016 May; 12(5):e1005590. PubMed ID: 27144308
[TBL] [Abstract][Full Text] [Related]
32. Naturally occurring amino acids differentially influence the development of Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae.
Al-Younes HM; Gussmann J; Braun PR; Brinkmann V; Meyer TF
J Med Microbiol; 2006 Jul; 55(Pt 7):879-886. PubMed ID: 16772415
[TBL] [Abstract][Full Text] [Related]
33. Damage/Danger Associated Molecular Patterns (DAMPs) Modulate Chlamydia pecorum and C. trachomatis Serovar E Inclusion Development In Vitro.
Leonard CA; Schoborg RV; Borel N
PLoS One; 2015; 10(8):e0134943. PubMed ID: 26248286
[TBL] [Abstract][Full Text] [Related]
34. Chlamydia trachomatis lacks an adaptive response to changes in carbon source availability.
Nicholson TL; Chiu K; Stephens RS
Infect Immun; 2004 Jul; 72(7):4286-9. PubMed ID: 15213176
[TBL] [Abstract][Full Text] [Related]
35.
Häuslein I; Sahr T; Escoll P; Klausner N; Eisenreich W; Buchrieser C
Open Biol; 2017 Nov; 7(11):. PubMed ID: 29093212
[No Abstract] [Full Text] [Related]
36. Structural characterization of muropeptides from Chlamydia trachomatis peptidoglycan by mass spectrometry resolves "chlamydial anomaly".
Packiam M; Weinrick B; Jacobs WR; Maurelli AT
Proc Natl Acad Sci U S A; 2015 Sep; 112(37):11660-5. PubMed ID: 26290580
[TBL] [Abstract][Full Text] [Related]
37. Unraveling the metabolism of HEK-293 cells using lactate isotopomer analysis.
Henry O; Jolicoeur M; Kamen A
Bioprocess Biosyst Eng; 2011 Mar; 34(3):263-73. PubMed ID: 20848294
[TBL] [Abstract][Full Text] [Related]
38. Persistence Alters the Interaction between Chlamydia trachomatis and Its Host Cell.
Brockett MR; Liechti GW
Infect Immun; 2021 Jul; 89(8):e0068520. PubMed ID: 34001559
[TBL] [Abstract][Full Text] [Related]
39. Chlamydia trachomatis utilizes the host cell microtubule network during early events of infection.
Clausen JD; Christiansen G; Holst HU; Birkelund S
Mol Microbiol; 1997 Aug; 25(3):441-9. PubMed ID: 9302007
[TBL] [Abstract][Full Text] [Related]
40. Metalloprotease inhibitors GM6001 and TAPI-0 inhibit the obligate intracellular human pathogen Chlamydia trachomatis by targeting peptide deformylase of the bacterium.
Balakrishnan A; Patel B; Sieber SA; Chen D; Pachikara N; Zhong G; Cravatt BF; Fan H
J Biol Chem; 2006 Jun; 281(24):16691-9. PubMed ID: 16565079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
